$2.5m contract to develop SynCardia's next generation TAH
Filed with ASX · · 3 pages · English
Hydrix Ltd (ASX: HYD) today announced that its wholly owned subsidiary Hydrix Services Pty Ltd (“Hydrix”) entered into a contract with SynCardia Systems LLC (“SynCardia”), a wholly owned subsidiary of Picard Medical, Inc. (NYSE American: PMI), to commence an initial development phase for SynCardia’s next-generation fully implantable Total Artificial Heart (TAH) technology, known as the Emperor. Pr
Earlier from Hydrix
- Reinstatement to official quotation - 13 October 2025
- Suspension from Quotation
- Timing of lodgement of FY25 accounts
- Response to ASX Price Query
- Preliminary Final Report
Later from Hydrix
- SynCardia and Hydrix Enter into Development Collaboration to Advance the Emperor, SynCardia’s Next Generation Total Artificial Heart
- Quarterly Activities/Appendix 4C Cash Flow Report
- Amended Appendix 4C
- Half Yearly Report and Accounts
- Trading Update and Growth Outlook
Follow Hydrix into a list and get an email when it puts out news.
Follow Hydrix